Literature DB >> 32147426

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).

Li Ren1, Dexiang Zhu1, Al B Benson2, Bernard Nordlinger3, Claus-Henning Koehne4, Conor P Delaney5, David Kerr6, Heinz-Josef Lenz7, Jia Fan8, Jianping Wang9, Jin Gu10, Jin Li11, Lin Shen12, Petrv Tsarkov13, Sabine Tejpar14, Shu Zheng15, Suzhan Zhang16, Thomas Gruenberger17, Xinyu Qin1, Xishan Wang18, Zhongtao Zhang19, Graeme John Poston20, Jianmin Xu21.   

Abstract

The liver is the most common anatomical site for hematogenous metastases from colorectal cancer. Therefore effective treatment of liver metastases is one of the most challenging elements in the management of colorectal cancer. However, there is rare available clinical consensus or guideline only focusing on colorectal liver metastases. After six rounds of discussion by 195 clinical experts of the Shanghai International Consensus Expert Group on Colorectal Liver Metastases (SINCE) from 29 countries or regions, the Shanghai Consensus has been finally completed, based on current research and expert experience. The consensus emphasized the principle of multidisciplinary team, provided detailed diagnosis approaches, and guided precise local and systemic treatments. This Shanghai Consensus might be of great significance to standardized diagnosis and treatment of colorectal liver metastases all over the world.
Copyright © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Colorectal liver metastases; Comprehensive therapy; Diagnosis; Multidisciplinary team

Mesh:

Year:  2020        PMID: 32147426     DOI: 10.1016/j.ejso.2020.02.019

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy.

Authors:  Jianhong Peng; Yujun Liu; Weihao Li; Yuzhu Lin; Hui Sun; Zhizhong Pan; Xiaojun Wu; Wenhua Fan; Junzhong Lin
Journal:  Therap Adv Gastroenterol       Date:  2021-12-19       Impact factor: 4.409

2.  AST·MLR index and operation injury condition are novel prognostic predictor for the prediction of survival in patients with colorectal cancer liver metastases undergoing surgical resection.

Authors:  Qichen Chen; Mingxia Li; Jinghua Chen; Zhen Huang; Xiao Chen; Hong Zhao; Jianqiang Cai
Journal:  BMC Cancer       Date:  2022-08-26       Impact factor: 4.638

3.  The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: A systematic review and meta-analysis.

Authors:  Shengjie Yang; Renze Peng; Leiming Zhou
Journal:  Front Med (Lausanne)       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.